Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 27, 2026
- Accession no.
- 0001193125-26-182316
- Filed
- Apr 27, 2026
- Trade date
- Apr 24, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $159.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | American depositary share | SSaleDisposed | −74 | $157.86F3 | −$11,681.64 | 9,592 | Direct | |
| Apr 24, 2026 | American depositary share | SSaleDisposed | −190 | $158.65F4 | −$30,143.5 | 9,402 | Direct | |
| Apr 24, 2026 | American depositary share | SSaleDisposed | −375 | $159.46F5 | −$59,797.5 | 9,027 | Direct | |
| Apr 24, 2026 | American depositary share | SSaleDisposed | −330 | $160.40F6 | −$52,932 | 8,697 | Direct | |
| Apr 24, 2026 | American depositary share | SSaleDisposed | −28 | $161.22F7 | −$4,514.16 | 8,669 | Direct | |
| Apr 24, 2026 | American depositary share | SSaleDisposed | −3 | $162.53 | −$487.59 | 8,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $157.81 to $157.9928. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $158.025 to $158.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $159.0063 to $159.9623. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $160 to $160.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $161.08 to $161.3562. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.